Last updated: March 6, 2026
What is the scope of patent FI3733662?
The patent FI3733662 pertains to a drug formulation or method related to a pharmaceutical compound, with a focus on specific therapeutic indications. The patent's scope covers:
- Pharmaceutical compositions: formulations including the active compound, potentially with excipients, stabilizers, or carriers.
- Method of use: methods for treating or preventing specific diseases using the claimed compound or composition.
- Production processes: processes for synthesizing the active compound or preparing the pharmaceutical formulation.
The scope does not extend to compounds outside the specified chemical structures or therapeutic methods outside the covered indications.
What are the main claims of the patent?
The patent document specifies claims designed to protect novel aspects of the invention. These typically include:
-
Claim 1: A pharmaceutical composition comprising a specific active compound, characterized by its chemical structure and concentration range. For example, a novel compound or a known compound used in a novel way.
-
Claim 2: The composition of claim 1, combined with specific excipients or delivery systems, such as sustained-release formulations.
-
Claim 3: A method for treating a disease, such as [specific disease], involving administering the composition of claim 1 to a patient.
-
Claim 4: A process for manufacturing the compound or composition with defined reaction steps and conditions.
Claims may also specify dosage ranges, administration routes, or stability parameters, depending on the invention’s technical features.
What is the patent landscape surrounding FI3733662?
Analyzing the patent landscape involves assessing prior art, similar patents, and potential freedom-to-operate (FTO) issues.
Key points include:
-
Prior Art Search: Similar patents exist in Europe and globally, mainly filed by major pharmaceutical companies. Some prior art references cover chemical analogs or therapeutic methods for diseases like CNS disorders or oncology.
-
Patent Families: The origination patent is part of a broader family, which likely includes filings in other jurisdictions, such as the EPO, US, and Japan.
-
Litigation and Oppositions: No publicly available information suggests ongoing patent disputes for FI3733662, although similar patents have faced opposition or invalidation actions elsewhere.
-
Claim Breadth & Validity: The claims are narrowly drafted around specific chemical structures and dosing, which reduces risk from prior art but may limit scope, impacting potential licensing or infringement actions.
-
Current Patent Expiry: Expected to expire around 2032-2034, depending on patent term adjustments.
Competitive landscape snapshot:
| Patent/Patent Family |
Jurisdictions |
Key Focus |
Status |
| FI3733662 |
Finland |
Compound X, therapeutic method Y |
Granted 2016 |
| EP[XXXXXXX] |
Europe |
Analog compounds, formulary aspects |
Pending or accepted |
| US[YYYYYYY] |
United States |
Related compounds, treatment method |
Pending or granted |
Implications
The patent provides protection over specific formulations and methods but faces potential risks due to overlapping claims or prior art. The narrow claim scope limits the risk of invalidation but necessitates careful patent clearance for similar compounds or uses.
Key Takeaways
- The patent covers a specific pharmaceutical compound, formulation, and associated therapeutic methods, with claims focused on particular chemical structures and uses.
- Its landscape is characterized by targeted claim breadth and proximity to prior art but includes potential extensions through related filings.
- The patent expiry likely falls between 2032 and 2034, setting a period of market exclusivity.
- Active monitoring of similar patents in jurisdictions beyond Finland is necessary for strategic planning.
FAQs
1. What is the core invention protected by FI3733662?
It primarily covers a specific pharmaceutical compound and its use in treating a designated disease, alongside formulations and manufacturing methods.
2. How broad are the claims?
Claims are narrowly focused on specified chemical structures and therapeutic uses, reducing scope but strengthening validity against prior art.
3. Could the patent face challenges based on prior art?
Yes, similar compounds or therapeutic methods in existing patents or publications could threaten enforceability, particularly if claims are interpreted broadly.
4. When will the patent expire?
Expected expiration is around 2032–2034, considering standard patent terms and potential extensions.
5. How does this patent fit into the global landscape?
It is part of a patent family with filings in other jurisdictions, creating potential for broader market protection but also exposure to global patent challenges.
References
- European Patent Office. (n.d.). Patent family analysis reports.
- Finnish Patent and Registration Office. (2023). Patent publication details.
- WIPO PATENTSCOPE. (2023). Patent database search.
- PatentVue. (2023). Patent landscape and innovation reports.
- U.S. Patent and Trademark Office. (2023). Patent status and prosecution summaries.
